Health Canada has issued a recall notice for compounded drugs containing semaglutide, which is a key component in popular medications like Ozempic and Wegovy.

Official data shows that since 2019, this medication has been linked to 23 deaths and 1,179 serious adverse reactions in the ...

Weight loss jabs are now are now available on the NHS for those with a prescription. But a black market for the in-demand ...

Specializing in cutting-edge treatments like Semaglutide and Tirzepatide, Zest Meds has positioned itself as a leader in the weight loss industry. Their approach is simple yet effective ...

It will grow from $20.54 billion in 2023 to $23.07 billion in 2024 at a compound annual growth rate ... anticipated to drive the expansion of the semaglutide market in the coming years.

The FDA clarifies that both Mounjaro single-dose vial products ... salt forms that should not be used to compound semaglutide, use of retatrutide in compounding, and adverse events related ...

A July 2024 study published in JAMA Ophthalmology found that semaglutide, the active ingredient in Ozempic and Wegovy, was linked to a higher risk of a rare eye condition known as "eye stroke," or non ...

Once there, he received 10 vials of antivenom, however, the swelling on his shin continued to increase. At first, the pain was so bad that he didn’t think it was the result of a snake bite.